Pharming Group N.V. (AMS:PHARM)
1.491
-0.037 (-2.39%)
Apr 16, 2026, 5:35 PM CET
Pharming Group Employees
Pharming Group had 407 employees as of December 31, 2025. The number of employees increased by 3 or 0.74% compared to the previous year.
Employees
407
Change (1Y)
3
Growth (1Y)
0.74%
Revenue / Employee
€787,109
Profits / Employee
€5,966
Market Cap
1.05B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 407 | 3 | 0.74% |
| Dec 31, 2024 | 404 | 22 | 5.76% |
| Dec 31, 2023 | 382 | 50 | 15.06% |
| Dec 31, 2022 | 332 | 55 | 19.86% |
| Dec 31, 2021 | 277 | 15 | 5.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Havas | 23,000 |
| Fugro | 9,062 |
| AMG Critical Materials | 3,640 |
| Corbion | 2,441 |
| Ferrari Group | 2,084 |
| OCI N.V. | 1,091 |
| Acomo | 840 |
| Flow Traders | 635 |
Pharming Group News
- 16 hours ago - Pharming Group announces the 2026 Annual General Meeting of Shareholders - GlobeNewsWire
- 9 days ago - Pharming Group to participate in April investor conferences - GlobeNewsWire
- 14 days ago - Pharming Group announces the filing of its 2025 Annual Report and Form 20-F - GlobeNewsWire
- 20 days ago - Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older - GlobeNewsWire
- 23 days ago - Pharming Group's Leniolisib Gets Japan Approval To Treat APDS Patients Aged 4 Years And Older - Nasdaq
- 23 days ago - Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older - GlobeNewsWire
- 5 weeks ago - Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow - GlobeNewsWire
- 6 weeks ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR - GlobeNewsWire